Total Payments
$1,251
2024 Payments
$731.79
Companies
20
Transactions
78
Medicare Patients
666
Medicare Billing
$62,464
Payment Breakdown by Category
Food & Beverage$1,251 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,251 | 78 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $397.27 | 20 | $0 (2024) |
| Novo Nordisk Inc | $146.56 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $103.90 | 9 | $0 (2023) |
| Axsome Therapeutics, Inc. | $80.74 | 5 | $0 (2024) |
| GlaxoSmithKline, LLC. | $72.00 | 5 | $0 (2024) |
| PFIZER INC. | $66.27 | 5 | $0 (2024) |
| Dynavax Technologies Corporation | $62.54 | 3 | $0 (2024) |
| Astellas Pharma US Inc | $49.69 | 3 | $0 (2024) |
| Lilly USA, LLC | $45.44 | 3 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $41.95 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $731.79 | 43 | ABBVIE INC. ($225.23) |
| 2023 | $244.29 | 14 | ABBVIE INC. ($158.81) |
| 2022 | $12.45 | 1 | Takeda Pharmaceuticals U.S.A., Inc. ($12.45) |
| 2021 | $55.40 | 4 | PFIZER INC. ($27.05) |
| 2020 | $77.28 | 5 | Alexion Pharmaceuticals, Inc. ($29.98) |
| 2019 | $86.03 | 7 | GlaxoSmithKline, LLC. ($41.22) |
| 2018 | $43.93 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($33.12) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.78 | General |
| 12/10/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Endocrinology | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: Neuropsychiatry | ||||||
| 11/01/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), FLUZONE HIGH-DOSE, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Vaccines | ||||||
| 10/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.55 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $13.25 | General |
| 09/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $7.36 | General |
| 09/12/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 08/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.49 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Biological | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.18 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: RESPIRATORY | ||||||
| 06/24/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.68 | General |
| 06/11/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 06/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Biological | ||||||
| 06/05/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $25.79 | General |
| Category: Hepatitis B Vaccine | ||||||
| 05/10/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.15 | General |
| 05/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.86 | General |
| Category: NEUROSCIENCE | ||||||
| 04/24/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 106 | 134 | $29,982 | $9,044 |
| 2022 | 6 | 257 | 350 | $71,612 | $27,122 |
| 2021 | 8 | 239 | 299 | $46,971 | $21,436 |
| 2020 | 3 | 64 | 68 | $10,994 | $4,862 |
Total Patients
666
Total Services
851
Medicare Billing
$62,464
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 77 | $19,250 | $4,816 | 25.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $4,072 | $2,458 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 37 | $6,660 | $1,770 | 26.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 82 | 131 | $32,750 | $11,243 | 34.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $11,918 | $7,379 | 61.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 72 | 100 | $18,000 | $5,527 | 30.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 24 | $8,160 | $2,747 | 33.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 12 | 20 | $480.00 | $191.80 | 40.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 13 | 16 | $304.00 | $35.65 | 11.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 89 | $17,309 | $7,041 | 40.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 45 | 45 | $9,090 | $5,625 | 61.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 70 | 95 | $12,726 | $5,560 | 43.7% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 12 | 12 | $3,960 | $1,909 | 48.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,298 | $676.32 | 29.4% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 11 | 11 | $814.00 | $409.31 | 50.3% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 13 | 18 | $432.00 | $174.78 | 40.5% |
| 81003 | Automated urinalysis test | Office | 2021 | 15 | 18 | $342.00 | $40.50 | 11.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 17 | 17 | $3,434 | $1,870 | 54.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 31 | 33 | $4,158 | $1,578 | 38.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 18 | $3,402 | $1,414 | 41.6% |
About Dr. Lindsey Nondorf, DO
Dr. Lindsey Nondorf, DO is a Family Medicine healthcare provider based in Shelbyville, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2017. The National Provider Identifier (NPI) number assigned to this provider is 1114455243.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lindsey Nondorf, DO has received a total of $1,251 in payments from pharmaceutical and medical device companies, with $731.79 received in 2024. These payments were reported across 78 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,251).
As a Medicare-enrolled provider, Nondorf has provided services to 666 Medicare beneficiaries, totaling 851 services with total Medicare billing of $62,464. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Shelbyville, IN
- Active Since 06/02/2017
- Last Updated 11/05/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1114455243
Products in Payments
- VRAYLAR (Drug) $278.32
- JARDIANCE (Drug) $93.34
- Auvelity (Drug) $80.74
- TRELEGY ELLIPTA (Drug) $72.00
- Heplisav-B (Drug) $62.54
- UBRELVY (Drug) $60.96
- QULIPTA (Drug) $57.99
- Veozah (Drug) $49.69
- INGREZZA (Drug) $41.95
- ELIQUIS (Drug) $37.86
- GEMTESA (Drug) $31.80
- Strensiq (Drug) $29.98
- Ozempic (Drug) $27.54
- XIFAXAN (Drug) $24.05
- MOUNJARO (Drug) $18.49
- NURTEC ODT (Drug) $17.56
- Crysvita (Drug) $15.64
- Tirosint (Drug) $14.67
- Cologuard Collection Kit (Device) $14.62
- BEYFORTUS (Biological) $14.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Shelbyville
Dr. Ron Creque, Md, MD
Family Medicine — Payments: $15,710
Family Medicine $15,710
Paul Goodlett, Md, MD
Family Medicine — Payments: $14,867
Family Medicine $14,867
Dr. David Oligschlaeger, D.o, D.O
Family Medicine — Payments: $11,457
Family Medicine $11,457
Beth Buchanan, Md, MD
Family Medicine — Payments: $10,835
Family Medicine $10,835
Dr. Emily Ann Andaya, Md, MD
Family Medicine — Payments: $8,149
Family Medicine $8,149
Meredith Kehrer, Md, MD
Family Medicine — Payments: $6,265
Family Medicine $6,265